India’s Manipal Health Jumps 10.5% in Market Debut, Valued at $9 Billion

India's Manipal Health jumps 10.5% in trading debut after $960 million IPO

Manipal Health Enterprises stock trades at ₹651 level after 11% premium debut

Manipal Health Enterprises debuts at ₹655, 11% above IPO price, amid strong demand and significant investor interest.

Manipal Health IPO Listing Live UPDATES: Shares to debut on bourses today, here's what GMP suggests

Ahead of the listing, Manipal Health's unlisted shares are trading at a grey market premium (GMP) of Rs 3. Considering the upper price band of Rs 590, the company's shares are expected to list at around Rs 593, reflecting a grey market premium of 0.51 per cent.

Manipal Health Enterprises shares to list today; GMP indicates flat debut

The company's IPO is currently commanding a grey market premium (GMP) of around Rs 3, or nearly 1% over the upper price band of Rs 590 per share, indicating an estimated listing price of Rs 593. While the GMP is widely tracked as a gauge of investor sentiment, it is an unofficial and unregulated indicator and should not be considered a reliable predictor of listing-day performance.

Manipal Health Enterprises IPO listing date today. Here’s what GMP, experts hint on share debut

Manipal Health Enterprises IPO is set to list today at 10:00 IST. The share price is estimated at ₹593, slightly above the IPO price of ₹590, despite a pessimistic outlook reflected in the GMP. Subscription was strong, with bids 4.92 times the shares offered.

Manipal Health IPO GMP: Signals for Investors

The initial public offering from Manipal Health Enterprises has been concluded, attracting significant institutional interest. The IPO was oversubscribed by 4.92 times, with most of the demand coming from the qualified institutional buyer (QIB) segment. Retail participation in the IPO fell far short of expectations and did not meet the full subscription quota expected of that market segment. The Grey Market Premium (GMP) reflects this divergence…